TTENK/calls
The BriefMarketsAll StocksNewsScreenerFeedback

Get the Brief in your inbox

A daily, SEC-grounded read on the market — movers, earnings, and our boldest calls. Free.

TTENK/calls

SEC-grounded equity research — opinionated calls reasoned over real filings.

Research

  • The Brief
  • Markets
  • All Stocks
  • Screener
  • Discover
  • Research
  • The Flip Side
  • Track record

Tools

  • Compare
  • Congress trades
  • Events
  • Filing search
  • Options calculator
  • Leaderboards
  • Insider trades
  • 13F funds
  • Groups
  • Trending
  • News

More

  • Pricing
  • Feedback
  • Newsletter
  • Developers / API
  • Account
DisclosuresTermsPrivacy

Research & education only — not financial advice.TENK is not a registered investment adviser; calls are impersonal, generated from SEC filings and a delayed/third-party price feed, and may be wrong or out of date. The operator and an affiliated trading operation may hold or trade the securities TENK rates — see Disclosures. Do your own research.

EDGAR® is a registered trademark of the U.S. Securities and Exchange Commission. TENK/calls is an independent service and is not affiliated with, endorsed by, or approved by the U.S. Securities and Exchange Commission.

TTENK/calls
The BriefMarketsAll StocksNewsScreenerFeedback

Pulling SEC filings + quote and writing the call…

TTENK/calls
The BriefMarketsAll StocksNewsScreenerFeedback
← New search
Home›Stocks›EQBK
EQBK logo

EQBK

EQUITY BANCSHARES INC

Next earnings Jul 13, 2026 · consensus $1.23 EPS, $86.4M rev

Last earnings +0.9% on 2026-04-14

Buy
$49.23
▲ +0.24%
$49.23▲ +21.29%
over 1Y
L $36.11H $49.61
Earnings Dividend Split Congress buy Congress sellGrouped by date · hover a pin to expand
Today+0.2%
1W+2.3%
1M+6.8%
3M+10.1%
YTD+10.2%
1Y+21.3%
OverviewFinancialsValuationQualityTimelineFilings
Rating
Buy
Quality
C-
Valuation
Overvalued
Filings
Flagged
Buy
Conviction
Horizon
Medium (3–12mo)
12-mo target
$•••
Street · 11 analysts
Buy

Headline 39x P/E masks the real story — strip the $53M bond loss and EQBK trades at ~11x core EPS with NIM expanding.

Diluted EPS (GAAP) $1.23 · FY2025

The read

The fundamentals carry the rating, but the price is rich (~81% above our fair-value estimate) — a quality-at-a-price call. The case rests on the business, not the entry; patient buyers may wait for a pullback.

The GAAP picture looks ugly — net income fell 63.7% to $22.7M and diluted EPS collapsed to $1.23 — but the 10-K makes clear this is a noise year, not a deterioration. The income statement carries a $53.2M loss on securities transactions (a one-time AFS portfolio repositioning) plus $8.1M of merger expense. Management's core EPS reconciliation lands at $4.39 vs. $4.43 in 2024 — essentially flat — and core ROAA of 1.42% and core ROAE of 11.58% are both improvements over prior-year core levels. At $48.52, that's roughly 11x core earnings and ~1.48x tangible book ($32.86), which is undemanding for a community bank actually growing.

The underlying engine is working. Net interest income jumped to $226.1M from $186.2M (+21%) as NIM expanded 35 bps to 4.33% — the cost of interest-bearing deposits actually fell to 2.47% from 2.80% while loan yields stayed at 7.04%. Gross loans grew 20% to $4.2B and deposits grew 17% to $5.14B, partly via M&A (goodwill stepped up to $103.7M from $68.1M). Capital is robust: CET1 13.08%, Tier 1 leverage 10.64%, total risk-based 16.31% — all well above 'well-capitalized' thresholds per the MD&A, leaving room to keep buying back stock ($14.0M in 2025) and to absorb the rising dividend ($11.4M, +44.7%).

Is EQBK a buy? The one-page verdict, explained →

The options angle

model · matches our verdict
Bull call spread~60d expiry
  • Long call 49 @ ~1.84 est
  • Short call 54 @ ~0.28 est
debit $156max +$344max −$156BE 50.56

BUY verdict with defined risk: the short call finances part of the long one; max loss is the net debit.

Open in the calculator →

Educational template, not a trade recommendation. Strikes and premiums are Black-Scholes model estimates from the last close and 30-day realized volatility — real chains, spreads and IV will differ. Options involve substantial risk.

Financials · annual, by fiscal year

Line itemFY21FY22FY23FY24FY25
Revenue—————
Gross profit—————
Operating income—————
Net income$52.5M$57.7M$7.82M$62.6M$22.7M
Diluted EPS$3.43$3.51$0.50$4.00$1.23
Net margin—————

10-year statements — income, cash flow, balance sheet & CSV export →

Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.

Key statistics

Valuation

Enterprise value—
EV / EBITDA—
EV / Sales—
EV / FCF—
P / FCF26.7
PEG (trailing)—
Earnings yield2.2%
FCF yield3.8%

Quality & risk

ROIC (est.)—
Free cash flow$38.1M
Total debt$443M
Net cash-$391M
Piotroski F-Score3/6

Capital returns

Buyback yield1.4%
Dividend yield (est.)1.1%
Shareholder yield2.5%
Shares Δ YoY+18.1%

Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.

Disclosure timeline

SEC · 8-Ks + reports
Recent disclosure tone has skewed negative — read the flagged items.
  1. 8-K Reg FD disclosure2026-06-17

    Reg FD investor presentation furnished; no new financial disclosures

  2. 8-K Other event2026-05-21

    Other-events disclosure, likely routine update on operations or capital

  3. 10-Q Quarterly report2026-05-08

    Q1 2026 results; NIM trends and credit costs in focus after weak FY25

  4. 8-K Officer / director change2026-04-22

    Annual meeting vote results and board/officer changes disclosed

  5. 8-K Earnings results2026-04-14

    Q1 2026 earnings release furnished with investor presentation

  6. 8-K/A Amended 8-K2026-03-18

    Amendment to prior 8-K, likely adding required financials for acquisition

  7. DEF 14A Proxy statement2026-03-12

    Proxy: director slate, exec pay, auditor ratification for annual meeting

  8. 10-K/A Restated periodic report2026-03-10

    Amended 10-K, typically Part III proxy info or minor correction

  9. 10-K Annual report2026-03-06

    FY25 EPS $1.23 vs $4.00, hit by $53M securities loss; NIM up to 4.33%

Recent filings

all on EDGAR ↗
8-KPeriod ending 2026-06-172026-06-17open ↗4Period ending 2026-06-112026-06-12open ↗144Filing2026-06-11open ↗4Period ending 2026-06-112026-06-11open ↗4Period ending 2026-06-092026-06-09open ↗S-8Filing2026-05-22open ↗8-KPeriod ending 2026-05-202026-05-21open ↗4Period ending 2026-05-182026-05-18open ↗10-QPeriod ending 2026-03-312026-05-08open ↗4Period ending 2026-05-062026-05-07open ↗4Period ending 2026-05-012026-05-05open ↗3Period ending 2026-04-212026-05-05open ↗

Quality score

C-
ValueGrowthProfitHealthMom.
ValueF
GrowthF
ProfitabilityD
Financial healthA-
MomentumA
  • ✓Profitable (positive net income)
  • ✗Return on equity above 15%
  • ✗P/E below 25

Fair value est.

$9.41

Overvalued -81% vs price

cheapfair valueexpensive

Modified Graham: EPS $1.23 × (8.5 + 1.5 × 0.0% growth) × 0.90 quality = 7.7× multiple. An estimate, not a price target.

35.9752-week50.20
Revenue
—
Net margin
—
ROE
3.1%
P/E
40.0

SEC fundamentals · FY 2025

'21'22'23'24'25

■ revenue · ■ net income, by fiscal year

Net income$22.7M-63.7%
Diluted EPS$1.23-69.3%
Cash & equivalents$52.2M+48.7%
Total assets$6.37B+19.5%
Total liabilities$5.64B+19.0%
Stockholders' equity$732M+23.5%
L/E: 7.71x

Frequently asked

Is EQUITY BANCSHARES INC (EQBK) a buy?
EQBK currently carries a Buy rating with 3/5 conviction, derived from its latest SEC filings. Headline 39x P/E masks the real story — strip the $53M bond loss and EQBK trades at ~11x core EPS with NIM expanding.
What is EQBK's fair value?
A Modified-Graham model based on EQBK's SEC fundamentals estimates a fair value of about $9.41. It is an estimate from reported earnings, not a price target.
Is EQBK overvalued or undervalued?
Against a Modified-Graham fair-value estimate, EQBK currently appears overvalued relative to its SEC-grounded earnings power.
What is EQUITY BANCSHARES INC's quality score?
EQBK scores 50.2707600955259/100 (grade C-) on a SEC-grounded quality model spanning value, growth, profitability, financial health and momentum.

Sources: SEC EDGAR (CIK 0001227500, latest 10-Q filed 2026-05-08) · EODHD · Proprietary analysis · as of 6/25/2026, 2:28:46 PM.

›About this recommendation — produced by TENK/calls (tenkcalls.com), Luxembourg · not investment advice

AI-generated analysis, produced by our proprietary engine from SEC filing data.

Investment recommendation produced by TENK/calls (tenkcalls.com), Luxembourg. Completed Jun 25, 2026, 10:28 AM ET. Ratings & methodology: definitions · All recommendations to date: track record · Conflicts: disclosures. Not investment advice.

Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.

Insider activity

Form 4 · SEC

Last 90 days: 0 open-market buys · 2 sales

2026-06-11
Maland Jerry P
Director
Gift2.23K
2026-06-11
Reber Brett A
General Counsel
Sell1.69K @ $47.85$80.7K
2026-06-09
Borck Leon
Director
Gift1.03K
2026-06-09
Borck Leon
Director
Gift1.03K
2026-05-18
Cook Kevin Earl
Director
Gift1.03K
2026-05-18
Cook Kevin Earl
Director
Gift1.03K
2026-05-06
Reber Brett A
General Counsel
Sell100.00 @ $46.55$4.66K
2026-05-01
Schlehuber Lisa Ann
Director
Award1.10K
2026-05-01
Everett Junetta M
Director
Award1.10K

Earnings history

beat/miss · move
2026-04-14Miss -32.0% est▼ -1.21%8-K ↗
2026-01-21Miss -5.1% est▲ +5.57%8-K ↗
2025-10-14Miss -344.0% est▼ -1.31%8-K ↗
2025-07-14Beat +3.8% est▼ -7.05%8-K ↗
2025-04-15—▲ +3.99%8-K ↗
2025-01-22—▲ +1.21%8-K ↗

Dates from 8-K (Item 2.02); beat/miss = reported EPS vs consensus (Finnhub, recent quarters); move = prior close → close on/after.

Vs tracked universe

compare →

1195 tracked peers · median

TENK Score50 vs 67
Revenue growth— vs 7.5%
Net margin— vs 10.0%
Return on equity3.1% vs 12.0%
P/E40.0 vs 26.2